Hans van Houte
CIK: 0001817217
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Nurix Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (55 total)
- Oct 30, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct2.8K shares at avg. $26.28$74K - Oct 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct3.6K shares- - Oct 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct2.9K shares- - Oct 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct3.8K shares- - Aug 4, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct1.8K shares at avg. $23.89$43K - Aug 4, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct3K shares at avg. $24.65$73K - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct2.9K shares- - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct3.8K shares- - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct2.8K shares at avg. $23.38$67K - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct3.6K shares- - May 5, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct582 shares at avg. $17.18$10K - May 5, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct13.5K shares at avg. $16.58$223K - Apr 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct3.8K shares- - Apr 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct2.9K shares- - Apr 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct2K shares- - Apr 30, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct2.4K shares at avg. $16.65$40K - Feb 10, 2026NRIX
Nurix Therapeutics, Inc.
Award(A)DirectEmployee Stock Option (right to buy)
93.8K shares- - Feb 10, 2026NRIX
Nurix Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
42.9K shares- - Jan 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct3.8K shares- - Jan 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct2.9K shares- - Jan 30, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct3.6K shares at avg. $16.58$59K - Jan 30, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct73 shares at avg. $17.37$1K - Jan 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct2.9K shares- - Jan 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct2K shares- - Nov 3, 2025NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct6.3K shares at avg. $12.56$79K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 30, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 2,834 | $26.28 | $74,475 | Direct |
| Oct 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 3,573 | - | $0 | Direct |
| Oct 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 2,859 | - | $0 | Direct |
| Oct 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 3,750 | - | $0 | Direct |
| Aug 4, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 1,794 | $23.89 | $42,861 | Direct |
| Aug 4, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 2,967 | $24.65 | $73,129 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 2,858 | - | $0 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 3,750 | - | $0 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 2,845 | $23.38 | $66,524 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 3,572 | - | $0 | Direct |
| May 5, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 582 | $17.18 | $9,996 | Direct |
| May 5, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 13,473 | $16.58 | $223,323 | Direct |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 3,750 | - | $0 | Direct |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 2,858 | - | $0 | Direct |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 2,000 | - | $0 | Direct |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 2,388 | $16.65 | $39,749 | Direct |
| Feb 10, 2026 | NRIX Nurix Therapeutics, Inc. | Award(A) Employee Stock Option (right to buy) | 93,750 | - | - | Direct |
| Feb 10, 2026 | NRIX Nurix Therapeutics, Inc. | Award(A) Restricted Stock Units | 42,875 | - | - | Direct |
| Jan 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 3,750 | - | $0 | Direct |
| Jan 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 2,859 | - | $0 | Direct |
| Jan 30, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 3,588 | $16.58 | $59,498 | Direct |
| Jan 30, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 73 | $17.37 | $1,268 | Direct |
| Jan 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 2,887 | - | $0 | Direct |
| Jan 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 2,000 | - | $0 | Direct |
| Nov 3, 2025 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 6,284 | $12.56 | $78,931 | Direct |
1-25 of 55 transactions
About van Houte Hans
van Houte Hans (SEC CIK 0001817217) files insider reports with the SEC as Chief Financial Officer of Nurix Therapeutics, Inc. (NRIX).
Signal8 holds 18 ownership filings by van Houte Hans, all Form 4s, filed between Oct 30, 2024 and Nov 2, 2026. Those filings report 55 transactions, from Oct 30, 2024 to Oct 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on van Houte Hans's filings is in BRISBANE, CA.
Recent filings by van Houte Hans
- Oct 30, 2026: Open-market sale of NRIX shares (Form 4, code S).
- Oct 30, 2026: Option exercises of NRIX shares (3 lines, Form 4, code M).
- Aug 4, 2026: Open-market sales of NRIX shares (2 lines, Form 4, code S).
- Jul 30, 2026: Option exercises of NRIX shares (2 lines, Form 4, code M).
- Jul 30, 2026: Open-market sale of NRIX shares (Form 4, code S).
Other insiders filing for Nurix Therapeutics, Inc. (NRIX)
- Ring Christine, Chief Legal Officer
- Hansen Gwenn, Chief Scientific Officer
- GREGORY JULIA P, Director
- Silva Paul M, Director
- Saltzman Edward C, Director
- Reinsdorf Judith A, Director